BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7126424)

  • 21. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
    Hall S
    Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HUMAN ACETYLATION POLYMORPHISM.
    EVANS DA; WHITE TA
    J Lab Clin Med; 1964 Mar; 63():394-403. PubMed ID: 14164493
    [No Abstract]   [Full Text] [Related]  

  • 26. Transformylation of carcinogenic aromatic by kynerenine formamidase: a detoxication mechanism.
    Santti RS; Hopsu-Havu VK
    Biochem Pharmacol; 1968 Jun; 17(6):1110-3. PubMed ID: 5661347
    [No Abstract]   [Full Text] [Related]  

  • 27. An improved and simplified method of detecting the acetylator phenotype.
    Evans DA
    J Med Genet; 1969 Dec; 6(4):405-7. PubMed ID: 5365949
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.
    Perry HM; Tan EM; Carmody S; Sakamoto A
    J Lab Clin Med; 1970 Jul; 76(1):114-25. PubMed ID: 4912962
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of the mononitro derivative of dapsone as a product from an oxidation in vitro.
    Tyler TR; Buhs RP; VandenHuevel WJ
    Biochem Pharmacol; 1973 Jun; 22(11):1383-5. PubMed ID: 4727788
    [No Abstract]   [Full Text] [Related]  

  • 30. N-hydroxylation of 4,4'-diaminodiphenylsulphone in liver microsomes and in vivo.
    Tabarelli S; Uehleke H
    Xenobiotica; 1971; 1(4):501-2. PubMed ID: 4152967
    [No Abstract]   [Full Text] [Related]  

  • 31. The partial fate of aminoglutethimide in man.
    Douglas JS; Nicholls PJ
    J Pharm Pharmacol; 1972 Dec; 24():Suppl:150P. PubMed ID: 4144875
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis of an active hydroxylated glutethimide metabolite and some related analogs with sedative-hypnotic and anticonvulsant properties.
    Aboul-Enein HY; Schauberger CW; Hansen AR; Fischer LJ
    J Med Chem; 1975 Jul; 18(7):736-41. PubMed ID: 1151995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artifacts formed in the metabolic study of pethidine.
    Stillwell WG; Lindberg C; Hartvig P
    Acta Pharm Suec; 1978; 15(1):71-5. PubMed ID: 645370
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoglutethimide in treatment of metastatic breast carcinoma.
    Smith IE; Fitzharris BM; McKinna JA; Fahmy DR; Nash AG; Neville AM; Gazet JC; Ford HT; Powles TJ
    Lancet; 1978 Sep; 2(8091):646-9. PubMed ID: 80576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphically acetylated aminoglutethimide in humans.
    Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
    Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.